Share of the population living with HIV receiving antiretroviral therapy in Madagascar

Madagascar: Share of the population living with HIV receiving antiretroviral therapy was 29.3% in 2024. ◆ Volatile

Latest (2024)
29.3%
Change on year
up 35.3%
World rank
142nd
of 149 countries
All-time high
29.3%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Madagascar, 1990–2024

01020301990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0 %2001: 0 %2002: 0 %2003: 0.075 %2004: 0.213 %2005: 0.3 %2006: 0.62 %2007: 0.822 %2008: 0.827 %2009: 0.959 %2010: 1.1 %2011: 1.4 %2012: 1.2 %2013: 1.6 %2014: 2.2 %2015: 3.2 %2016: 4.2 %2017: 5.2 %2018: 7.3 %2019: 10 %2020: 10.4 %2021: 14.6 %2022: 18.3 %2023: 21.6 %2024: 29.3 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

Madagascar recorded 29.3% for share of the population living with hiv receiving antiretroviral therapy in 2024. That is the highest value across all 35 years on record.

That represents a change of up 35.3% on the previous year and up 1,238.8% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Madagascar peaked at 29.3% in 2024 and was at its lowest, 0.0%, in 1990.

That places Madagascar 142nd out of 149 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Madagascar, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Madagascar, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.0% —
2001 0.0% —
2002 0.0% —
2003 0.1% —
2004 0.2% +185.7%
2005 0.3% +40.9%
2006 0.6% +106.5%
2007 0.8% +32.6%
2008 0.8% +0.6%
2009 1.0% +15.9%
2010 1.1% +10.9%
2011 1.4% +34.6%
2012 1.2% -14.1%
2013 1.6% +29.0%
2014 2.2% +37.9%
2015 3.2% +48.3%
2016 4.2% +28.3%
2017 5.2% +26.1%
2018 7.3% +39.9%
2019 10.0% +35.7%
2020 10.4% +4.9%
2021 14.6% +40.2%
2022 18.3% +24.9%
2023 21.6% +18.4%
2024 29.3% +35.3%

Madagascar compared with similar countries

  • Madagascar's 29.3% is below the median for low income countries, which is 69.8%, 42% of the median. (24 countries reporting)
  • Madagascar's 29.3% is below the median for Sub-Saharan Africa, which is 81.2%, 36% of the median. (44 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Madagascar changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +185.7% 0.1% 0.2%
2006 +106.5% 0.3% 0.6%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 0.4% 0.0% 1.0% 10
2010s 3.7% 1.1% 10.0% 10
2020s 18.9% 10.4% 29.3% 5

Countries ranked near Madagascar

  1. 139 Mongolia 40.6% compare
  2. 140 Philippines 40.4% compare
  3. 141 Congo 33.7% compare
  4. 143 Tunisia 28.9% compare
  5. 144 Yemen 28.7% compare
  6. 145 Djibouti 24.7% compare

See the full ranking of 149 places →

More reference data data for Madagascar

All data for Madagascar →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Madagascar?
Share of the population living with hiv receiving antiretroviral therapy in Madagascar was 29.3% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Madagascar?
The highest recorded value was 29.3% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Madagascar?
The lowest recorded value was 0.0% in 1990.
How does Madagascar rank for share of the population living with hiv receiving antiretroviral therapy?
Madagascar ranks 142nd out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Madagascar?
Over the last ten years it is up 1,238.8%. The long-run trend across the full record is volatile.
Where does this Madagascar data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Madagascar. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/madagascar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/madagascar/">Share of the population living with HIV receiving antiretroviral therapy in Madagascar</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.